Unusual computed tomography findings in hepatic amyloidosis

Marmolya, Gary; Karlins, Nathaniel L.; Petrelli, Mary; McCullough, Arthur J.

doi:10.1016/0899-7071(90)90084-o

Cited by 11 publications

(2 citation statements)

References 11 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…11). 48 Delayed enhancement on contrast-enhanced CT of these areas has been reported. 48 The MRI findings in hepatic amyloidosis are not well defined yet.…”

mentioning

confidence: 94%

See 1 more Smart Citation

Imaging of Diffuse Liver Disease

Mortelé¹,

Ros²

2001

Semin Liver Dis

View full text Add to dashboard Cite

Advances in imaging technology and development of liver-specific contrast agents have significantly increased the role of radiology in the detection and characterization of processes diffusely involving the liver. Tailored magnetic resonance imaging (MRI) sequences allow an accurate detection of many storage and metabolic diseases, such as iron overload disorders and steatosis (fatty liver). Faster scanning techniques available with both computed tomography (CT) and MRI provide, by assessing contrast dynamics, sufficient information for the characterization of diffuse neoplastic and vascular disorders. Characteristic changes in attenuation on CT, signal intensity on MRI, and enhancing features can be used to diagnose specific diffuse diseases such as candidiasis, diffuse/multifocal hepatocellular carcinoma, and schistosomiasis. Although an overlap in imaging findings still exists, familiarity with the imaging features of uncommon disorders such as Wilson's disease, amyloidosis, and sarcoidosis may be diagnostic in the proper clinical setting. This review focuses on the current role of imaging in the detection and characterization of diffuse liver disorders. Recent developments that have amplified the role of noninvasive diagnostic evaluation of these conditions are especially highlighted.

show abstract

“…11). 48 Delayed enhancement on contrast-enhanced CT of these areas has been reported. 48 The MRI findings in hepatic amyloidosis are not well defined yet.…”

mentioning

confidence: 94%

“…48 Delayed enhancement on contrast-enhanced CT of these areas has been reported. 48 The MRI findings in hepatic amyloidosis are not well defined yet. Two existing reports demonstrate that no specific MRI findings allow differentiation between amyloidosis and other diffuse liver processes.…”

mentioning

confidence: 94%